Myeloma

U.S. DOD awards $1.6 million contract to develop bone-targeting nanocapsules

Published in Cancer Weekly, April 26th, 2005

The U.S. Department of Defense has awarded a 3-year, $1.6 million contract to Southwest Research Institute to develop bone-targeting nanocapsules for fighting myeloma and metastatic bone cancers. These secondary bone cancers are more common and deadly than primary bone cancer, which is rare.

More than 500,000 people will die from cancer in 2005, and most of these patients will have been affected by metastasis, cancer that started elsewhere in the body and spread to the bone. Myeloma, a blood-borne disease that is uniformly fatal, affects approximately 70,000 Americans and accounts for about 2% of all cancer deaths.

The program is intended to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2005-04-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry